Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
Efficacy of Low Dose Isotretinoin Versus Excimer Light as an Adjuvant for Itraconazole in Treatment of Onychomycosis: a Randomized Controlled Trial.
Zagazig University
36 participants
Jul 12, 2024
INTERVENTIONAL
Conditions
Summary
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
Eligibility
Inclusion Criteria1
- patients with onychomycosis
Exclusion Criteria1
- pregnant and lactating females patients on statin therapy or photosensitizing drugs patients with liver disease, heart disease and diabetes milletus.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Low dose isotretinoin as an adjuvant for itraconazole in treating onychomycosis
excimer light as an adjuvant for itraconazole in treating onychomycosis
Itraconazole alone
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06485505